Therefore, we recommend that SF1 + TRA2B + THRAP3 and THRAP3 + RHOA + QRICH1 be adopted as the RG combinations for breast cancer tissue and cell line research, respectively. This evidence concerns the gene SF1 and breast carcinoma.